MSDx logo — WINDOW INTO THE BRAIN™ - Empowering early detection and impr...

MSDx

WINDOW INTO THE BRAIN™ - Empowering early detection and improved care for brain disorders through innovative blood tests.

Founded 2005 Series A Biotechnology, Health Care +1

General Information

Company Name MSDx
Founded Year 2005
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with MSDx. To contact MSDx, visit msdx.co.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MSDx compare?

A PDF of MSDx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MSDx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MSDx

MSDx is a personalized medicine company founded in 2005 with a focus on developing blood testing products for brain diseases. The company’s slogan, "WINDOW INTO THE BRAIN™," represents its aim to empower early detection and improved care for brain disorders through innovative blood tests. With a commitment to providing essential data for diagnosis, monitoring, and assessing therapeutic response, MSDx addresses the significant gap in available blood tests for brain damage, impacting millions of people. Particularly crucial for neurological diseases, the company's patented blood test panel, "WINDOW INTO THE BRAIN™," aims to provide cost-effective, reliable, blood-based biomarkers aiding in disease detection before excessive damage occurs. The company's Series A investment at 18 February 2016 was received from MergeLane, indicating early interest and support from investors in the biotechnology, health care, and pharmaceutical industries.

Business keywords: personalized medicine, blood testing, brain diseases, biomarkers, neurological diseases, diagnosis, monitoring, therapeutic response, early detection, cost-effective, reliable, patented

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
MergeLane
18 Feb 2016

MSDx Alternatives & Competitors

View All Alternatives
MSDx vs

Pioneering early cancer diagnosis through advanced fluid biopsy technology

Series A
11-50 employees
Biotechnology, Health Care
MSDx vs
Epi One
Epi One United States

Taking Cancer Diagnosis to the Next Level

Angel
3 employees
Biotechnology, Health Care
MSDx vs
Avenna Ltd
Avenna Ltd United Kingdom

Biotech Startup specialised in development of practical, precision healthcare solutions for inflamma...

6 employees
Biotechnology, Health Care

FAQ About MSDx

WINDOW INTO THE BRAIN™ - Empowering early detection and improved care for brain disorders through innovative blood tests.
MSDx was founded in 2005.
MSDx operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on personalized medicine, blood testing, brain diseases and biomarkers.
MSDx has completed 1 funding round. The latest funding stage is Series A.
Top alternatives and competitors to MSDx include ARNA Genomics, Epi One, Avenna Ltd, ACT Genomics, Satoris Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MSDx and ARNA Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MSDx, https://bouncewatch.com/company/msdx, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes